XL999 Terminated Phase 2 Trials for Ovarian Cancer Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00277290Study of XL999 in Patients With Previously Treated Ovarian Cancer